Trademarkia Logo

Australia

AU$
MERCK SHARP & DOHME
Accepted: In opposition period

Last updated on 21 Mar 2025

Owner Info

Merck Sharp & Dohme B.V.

Waarderweg 39

NL-2031 BN Haarlem, THE NETHERLANDS

Serial Number

2469040 filed on 12 Jun 2024

Correspondent

Hogan Lovells (Alicante) S.L. & Cia.

Avenida Federico Soto, 13,

E-03003 Alicante,

SPAIN

MERCK SHARP & DOHME

Classification Information


Class [005]
Pharmaceuticals and vaccines for human and veterinary use; medicinal, pharmaceutical, therapeutic, and biological preparations for internal use and to Read More

Class [009]
Downloadable software and computer hardware for collecting, monitoring, analyzing, managing, processing, sharing and accessing patient health, medical Read More

Class [010]
Surgical apparatus and instruments for medical or veterinary use; medical instruments and apparatus for diagnosing and treating autoimmune, bone, card Read More

Class [035]
Business support services to start-up companies in the pharmaceutical, healthcare, veterinary, and biomedical fields by providing them with technology Read More

Class [041]
Educational services, namely, conducting programs in the fields of medicine, healthcare, pharmaceuticals, and animal health, and distribution of educa Read More

Class [042]
Providing medical research information in the fields of pharmaceuticals, clinical trials, and veterinary preparations; medical, scientific, veterinary Read More

Class [044]
Providing information in the fields of healthcare, pharmaceuticals, medicines, and animal health, including via a website; charitable services, namely Read More

Mark Details


Serial Number

2469040

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

21 Dec 2023

Mark Type

JM

Legal History


Show more

Status DateAction Taken
21st Mar 2025Application Accepted correspondence sent
20th Mar 2025Application Accepted correspondence sent
20th Mar 2025IP Right has been Examined
20th Mar 2025IP Right Acceptance Published
20th Mar 2025Status change to Accepted
19th Mar 2025Examination Response Received
20th Feb 2025Adverse Report (Examination) correspondence sent
20th Feb 2025IP Right has been Examined
19th Feb 2025Examination Response Received
14th Nov 2024Customer Amendment Made correspondence sent